301 related articles for article (PubMed ID: 9443745)
21. 99mTc-HL91 "hot spot" imaging of mice bearing human carcinoma by gamma camera and the effects of tumor necrosis on imaging.
Yao Z; Qu W; Zhou Y; Zhu M; Zhu L
Chin Med J (Engl); 2000 May; 113(5):404-7. PubMed ID: 11776093
[TBL] [Abstract][Full Text] [Related]
22. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Honess DJ; Hill SA; Collingridge DR; Edwards B; Brauers G; Powell NA; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):731-5. PubMed ID: 9845086
[TBL] [Abstract][Full Text] [Related]
24. The preparation and biological characterization of a new HL91-derivative for hypoxic imaging on stroke mice.
Hsia CC; Huang FL; Lin CH; Shen LH; Wang HE
Appl Radiat Isot; 2010 Sep; 68(9):1610-5. PubMed ID: 20395152
[TBL] [Abstract][Full Text] [Related]
25. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
26. Assessment of reperfused myocardium using a new ischaemia-avid imaging agent, technetium-99m HL91: comparison with myocardial glucose uptake.
Fukuchi K; Kusuoka H; Yutani K; Hasegawa S; Nishimura T
Eur J Nucl Med; 1998 Apr; 25(4):361-6. PubMed ID: 9553165
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime).
Suzuki T; Nakamura K; Kawase T; Kubo A
Ann Nucl Med; 2003 Apr; 17(2):131-8. PubMed ID: 12790362
[TBL] [Abstract][Full Text] [Related]
28. 99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.
Van De Wiele C; Versijpt J; Dierckx RA; Moerman M; Lemmerling M; D'Asseler Y; Vermeersch H
Nucl Med Commun; 2001 Mar; 22(3):269-75. PubMed ID: 11314758
[TBL] [Abstract][Full Text] [Related]
29. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
31. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
[TBL] [Abstract][Full Text] [Related]
33. Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia.
Lee BF; Wang LW; Lin SH; Jhuo TJ; Chiu NT; Huang CC; Hsia CC; Shen LH
Crit Care Med; 2012 Jun; 40(6):1930-8. PubMed ID: 22610194
[TBL] [Abstract][Full Text] [Related]
34. Fluorine-18-FDG PET in Paget's disease of bone.
Cook GJ; Maisey MN; Fogelman I
J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
[TBL] [Abstract][Full Text] [Related]
35. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Imran MB; Kubota K; Yamada S; Fukuda H; Yamada K; Fujiwara T; Itoh M
J Nucl Med; 1998 Jul; 39(7):1219-23. PubMed ID: 9669398
[TBL] [Abstract][Full Text] [Related]
36. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-HL91 is inferior to 201Tl in scintigraphic detection of chronic myocardial ischaemia.
Wu YW; Lee CM; Huang YH; Chou NK; Yen RF; Tzen KY; Huang PJ
Nucl Med Commun; 2005 Dec; 26(12):1119-23. PubMed ID: 16264360
[TBL] [Abstract][Full Text] [Related]
38. [Biodistribution of hypoxic marker, 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)].
Suzuki T; Nakamura K; Kawase T; Kubo A
Kaku Igaku; 2001 Jul; 38(4):333-41. PubMed ID: 11530380
[TBL] [Abstract][Full Text] [Related]
39. Discordance between FDG uptake and technetium-99m-HMPAO brain perfusion in acute traumatic brain injury.
Abu-Judeh HH; Singh M; Masdeu JC; Abdel-Dayem HM
J Nucl Med; 1998 Aug; 39(8):1357-9. PubMed ID: 9708506
[TBL] [Abstract][Full Text] [Related]
40. PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
Pauleit D; Stoffels G; Schaden W; Hamacher K; Bauer D; Tellmann L; Herzog H; Bröer S; Coenen HH; Langen KJ
J Nucl Med; 2005 Mar; 46(3):411-6. PubMed ID: 15750152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
